Latest Schedule 13G passive stakes

Capital Research Global Investors has updated its beneficial ownership filing for Carrier Global Corp., reporting a 12.8% stake.

Capital Research Global Investors has updated its beneficial ownership filing for JBS N.V., reporting a 4.4% stake.

Capital Research Global Investors has disclosed a beneficial ownership of 19,459,649 shares, representing 6.9% of Ovintiv Inc.'s common stock as of June 30, 2026.

Capital Research Global Investors has disclosed a beneficial ownership of 6.4% in Blue Owl Capital Inc., holding 43,196,688 shares.

Capital Research Global Investors reports a 11.4% beneficial ownership of Patria Investments Ltd. common stock as of June 30, 2026.

Capital Research Global Investors has reported beneficial ownership of 3,595,083 shares, representing 5.2% of Arxis, Inc.'s common stock, as of June 30, 2026.

MAK Capital Fund LP, MAK Capital One LLC, and Michael A. Kaufman have jointly filed a Schedule 13G/A, reporting beneficial ownership of 2,375,861 shares, representing 7.8% of ClearPoint Neuro, Inc.'s common stock.

Goldman Sachs Asset Management, L.P. has updated its beneficial ownership filing for PICS NV, now holding 7.3% of the company's Class A common shares.

A Schedule 13G filing reveals significant beneficial ownership of AirSculpt Technologies, Inc. common stock by entities associated with Vesey Street Capital Partners.

Massachusetts Financial Services Company has reported a beneficial ownership of 4.7% in PG&E Corp's common stock as of June 30, 2026.

Massachusetts Financial Services Company has updated its beneficial ownership filing for Nasdaq, Inc., reporting a 4.1% stake.

Massachusetts Financial Services Company has updated its beneficial ownership filing for TransUnion, now holding 5.6% of the company's common stock.

Massachusetts Financial Services Company has disclosed a beneficial ownership of 4.5% in Ashland Inc. common stock as of June 30, 2026.

Massachusetts Financial Services Company has reported beneficial ownership of 6,818,266 shares, representing 6.8% of the outstanding common stock of Blackstone Digital Infrastructure Trust Inc.

Morgan Stanley and its subsidiary, Morgan Stanley Capital Services LLC, have filed an amendment to their Schedule 13G, reporting a decrease in their beneficial ownership of Magnera Corp's common stock to below the 5% threshold.

Morgan Stanley and its subsidiary, Morgan Stanley Capital Services LLC, have filed an amendment to their Schedule 13G, reporting a decrease in their beneficial ownership of Magnera Corp's common stock to below the 5% threshold.

Several entities associated with Scotiabank have adjusted their beneficial ownership stake in TFI International Inc., now collectively holding 3.079% of the company's common shares.

Jane Street Group, LLC and its affiliates have reported a beneficial ownership stake of 5.3% in CXApp Inc. common stock as of June 30, 2026.

Morgan Stanley and its subsidiary have reported a decrease in their beneficial ownership of Cohen & Steers Select Preferred & Income Fund, Inc. common stock to below the 5% threshold.

Morgan Stanley and its subsidiary have reported a decrease in their beneficial ownership of Cohen & Steers Select Preferred & Income Fund, Inc. common stock to below the 5% threshold.

Goldman Sachs Group, Inc. and its subsidiary Goldman Sachs & Co. LLC have reported beneficial ownership of 6.4% of Mountain Crest Acquisition 6's ordinary shares.

Goldman Sachs Group, Inc. and its subsidiary Goldman Sachs & Co. LLC have reported beneficial ownership of 6.4% of Mountain Crest Acquisition 6's ordinary shares.

A Schedule 13G filing reveals that 1832 Asset Management L.P., MD Financial Management Inc., and Scotia Capital Inc. collectively hold a 6.4% stake in CAE Inc. as of June 30, 2026.

The Goldman Sachs Group, Inc. and its subsidiary Goldman Sachs & Co. LLC have reported beneficial ownership of 7.2% of GalaxyEdge Acquisition Corporation's ordinary shares as of June 30, 2026.

The Goldman Sachs Group, Inc. and its subsidiary Goldman Sachs & Co. LLC have reported beneficial ownership of 7.2% of GalaxyEdge Acquisition Corporation's ordinary shares as of June 30, 2026.

Morgan Stanley entities have reported a decrease in their beneficial ownership of C4 Therapeutics, Inc. common stock, now holding less than 5% collectively.

Morgan Stanley entities have reported a decrease in their beneficial ownership of C4 Therapeutics, Inc. common stock, now holding less than 5% collectively.

Goldman Sachs Group, Inc. and its subsidiary Goldman Sachs & Co. LLC have filed a Schedule 13G, reporting beneficial ownership of 7.1% of Newbridge Acquisition Limited's Class A Ordinary Shares as of June 30, 2026.

Goldman Sachs Group, Inc. and its subsidiary Goldman Sachs & Co. LLC have filed a Schedule 13G, reporting beneficial ownership of 7.1% of Newbridge Acquisition Limited's Class A Ordinary Shares as of June 30, 2026.

Jane Street Group, LLC and its affiliates have reported beneficial ownership of 20,125,585 shares, representing 6.3% of Core Scientific, Inc.'s common stock.